Your guide to beginning therapy with JARDIANCE®
Keep this card with you all the times
This educational material is essential to ensure the safe and appropriate use of JARDIANCE , it is advised
to be read carefully before using it.
Any adverse reactions should be reported in accordance with the Saudi Vigilance spontaneous reporting
system to:
The National Pharmacovigilance and Drug Safety Centre NPC
Email: npc.drug@sfda.gov.sa
Fax: +966112057662
Phone : +966-11-2038222 Ext: 2340-2334-2354-2353-2356-2317
Toll free phone: 8002490000
In addition, suspected adverse reactions related Boehringer Ingelheim products may be reported to
Boehringer Ingelheim.
Pharmacovigilance department:
Email: PV_local_Saudi_Arabia@boehringer-ingelheim.com
Phone:+966-11-2078275
PATIENT